10-Q · 2026-11-06
Treace Medical Concepts, Inc. releases Q3 results showing growth and operational updates, reflecting commitment to transparency in the surgical instruments sector.
| Name | TREACE MEDICAL CONCEPTS, INC. |
|---|---|
| CIK | 0001630627 |
| Tickers | TMCI |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Accelerated filer |
| SIC | 3841 Surgical & Medical Instruments & Apparatus |
| EIN | 471052611 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | FL FL |
| Phone | (904) 373-5940 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Treace Medical Concepts, Inc. releases Q3 results showing growth and operational updates, reflecting commitment to transparency in the surgical instruments sector.
Treace Medical Concepts, Inc. announces its financial results for Q3 2026, showcasing growth and innovation in the surgical instruments market.
447 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005301 | 005-93221 | 261559237 | 34 | 10061 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005257 | 005-93221 | 261558220 | 34 | 10253 | |||
| 2026-11-06 | 10-Q | 10-Q | 0001193125-26-450722 | 001-40355 | 261529306 | 34 | 8211951 | 1 | 1 | |
| 2026-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-450715 | 001-40355 | 261529300 | 34 | 751045 | 1 | 1 |
| 2026-10-28 | 4 | 4 | 0001193125-26-436510 | 4965 | ||||||
| 2026-10-02 | 4 | 4 | 0001193125-26-412727 | 4825 | ||||||
| 2026-08-24 | 4 | 4 | 0001193125-26-363737 | 11963 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003617 | 005-93221 | 261277310 | 34 | 10500 | |||
| 2026-08-12 | 4 | 4 | 0001193125-26-347275 | 4966 | ||||||
| 2026-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-347227 | 005-93221 | 261268935 | 34 | 7323 | |||
| 2026-08-12 | 4 | 4 | 0001193125-26-347223 | 4719 | ||||||
| 2026-08-12 | 4 | 4 | 0001193125-26-347222 | 4767 | ||||||
| 2026-08-07 | 10-Q | 10-Q | 0001630627-26-000018 | 001-40355 | 261251391 | 34 | 8149847 | 1 | 1 | |
| 2026-08-07 | 8-K | 8-K | 2.02,9.01 | 0001630627-26-000017 | 001-40355 | 261251390 | 34 | 726478 | 1 | 1 |
| 2026-07-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003113 | 005-93221 | 261221114 | 34 | 10797 | |||
| 2026-06-12 | 4/A | 4/A | 0001193125-26-268606 | 11386 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267800 | 10551 | ||||||
| 2026-06-01 | 4 | 4 | 0001193125-26-251587 | 8604 | ||||||
| 2026-05-28 | 4 | 4 | 0001193125-26-245341 | 12497 | ||||||
| 2026-05-20 | 8-K | 8-K | 5.07,9.01 | 0001630627-26-000014 | 001-40355 | 261005225 | 34 | 194486 | 1 | 1 |
| 2026-05-19 | 4 | 4 | 0001193125-26-231466 | 6843 | ||||||
| 2026-05-19 | 4 | 4 | 0001193125-26-231464 | 5318 | ||||||
| 2026-05-19 | 4 | 4 | 0001193125-26-231462 | 5322 | ||||||
| 2026-05-19 | 4 | 4 | 0001193125-26-231463 | 5076 | ||||||
| 2026-05-19 | 4 | 4 | 0001193125-26-231461 | 5362 | ||||||
| 2026-05-19 | 4 | 4 | 0001193125-26-231459 | 5374 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-002152 | 005-93221 | 26984155 | 34 | 10496 | |||
| 2026-05-14 | 4 | 4 | 0001193125-26-224391 | 12496 | ||||||
| 2026-05-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000302 | 005-93221 | 26979028 | 34 | 171307 | |||
| 2026-05-08 | S-8 | S-8 | 0001630627-26-000011 | 333-295702 | 26958237 | 33 | 638406 | 1 | 1 | |
| 2026-05-08 | 10-Q | 10-Q | 0001193125-26-213322 | 001-40355 | 26956029 | 34 | 7093302 | 1 | 1 | |
| 2026-05-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-213267 | 001-40355 | 26956013 | 34 | 624002 | 1 | 1 |
| 2026-04-20 | 4 | 4 | 0001193125-26-164654 | 4718 | ||||||
| 2026-04-09 | 8-K | 8-K | 2.02,5.02,7.01 | 0001630627-26-000010 | 001-40355 | 26849783 | 34 | 181392 | 1 | 1 |
| 2026-04-06 | ARS | ARS | 0001630627-26-000007 | 001-40355 | 26839697 | 34 | 5618606 | |||
| 2026-04-06 | DEFA14A | DEFA14A | 0001630627-26-000006 | 001-40355 | 26839694 | 34 | 1168224 | |||
| 2026-04-06 | DEF 14A | DEF 14A | 0001630627-26-000005 | 001-40355 | 26839693 | 34 | 39954939 | 1 | 1 | |
| 2026-04-03 | 4 | 4 | 0001193125-26-142647 | 5259 | ||||||
| 2026-03-11 | 4 | 4 | 0001193125-26-102764 | 6111 | ||||||
| 2026-03-11 | 4 | 4 | 0001193125-26-102763 | 6097 | ||||||
| 2026-03-11 | 4 | 4 | 0001193125-26-102762 | 9400 | ||||||
| 2026-03-11 | 4 | 4 | 0001193125-26-102761 | 6063 | ||||||
| 2026-02-27 | 10-K | 10-K | 0001193125-26-079167 | 001-40355 | 26692566 | 34 | 55447844 | 1 | 1 | |
| 2026-02-27 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-079163 | 001-40355 | 26692555 | 34 | 768144 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001222 | 005-93221 | 26645044 | 34 | 10534 | |||
| 2026-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001019056-26-000033 | 005-93221 | 26627961 | 34 | 12055 | |||
| 2026-02-11 | 4 | 4 | 0001193125-26-047313 | 6908 | ||||||
| 2026-02-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001644956-26-000008 | 005-93221 | 26611131 | 34 | 6677 | |||
| 2026-01-23 | 4 | 4 | 0001193125-26-021453 | 5147 | ||||||
| 2026-01-23 | 4 | 4 | 0001193125-26-021452 | 6627 | ||||||
| 2026-01-23 | 4 | 4 | 0001193125-26-021451 | 6580 | ||||||
| 2026-01-23 | 4 | 4 | 0001193125-26-021450 | 8902 | ||||||
| 2026-01-23 | 4 | 4 | 0001193125-26-021449 | 9926 | ||||||
| 2026-01-13 | 4 | 4 | 0001193125-26-012082 | 4580 | ||||||
| 2026-01-13 | 4 | 4 | 0001193125-26-012081 | 4628 | ||||||
| 2026-01-13 | 4 | 4 | 0001193125-26-012080 | 7927 | ||||||
| 2026-01-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-26-011177 | 001-40355 | 26528548 | 34 | 10539414 | 1 | 1 |
| 2025-12-18 | 8-K | 8-K | 1.01,1.02,2.03,3.03,7.01,8.01,9.01 | 0001193125-25-323802 | 001-40355 | 251581407 | 34 | 248416 | 1 | 1 |
| 2025-12-03 | 4 | 4 | 0001193125-25-307269 | 6017 | ||||||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-005159 | 005-93221 | 251488673 | 34 | 10664 | |||
| 2025-11-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001644956-25-000047 | 005-93221 | 251474604 | 34 | 6531 | |||
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-269556 | 001-40355 | 251458471 | 34 | 7908821 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-25-269481 | 001-40355 | 251458250 | 34 | 732628 | 1 | 1 |
| 2025-10-28 | 4 | 4 | 0001193125-25-253801 | 4614 | ||||||
| 2025-10-28 | 4 | 4 | 0001193125-25-253800 | 4628 | ||||||
| 2025-10-02 | 4 | 4 | 0001193125-25-228960 | 6113 | ||||||
| 2025-08-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003633 | 005-93221 | 251223544 | 34 | 10661 | |||
| 2025-08-12 | 4 | 4 | 0000950170-25-107557 | 4630 | ||||||
| 2025-08-12 | 4 | 4 | 0000950170-25-107556 | 4582 | ||||||
| 2025-08-12 | 4 | 4 | 0000950170-25-107555 | 4615 | ||||||
| 2025-08-12 | 4 | 4 | 0000950170-25-107554 | 4598 | ||||||
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-105059 | 001-40355 | 251194326 | 34 | 7804510 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-105039 | 001-40355 | 251194175 | 34 | 730902 | 1 | 1 |
| 2025-07-22 | 4 | 4 | 0000950170-25-097601 | 7120 | ||||||
| 2025-05-21 | 4 | 4 | 0000950170-25-075894 | 4937 | ||||||
| 2025-05-21 | 4 | 4 | 0000950170-25-075893 | 5184 | ||||||
| 2025-05-21 | 4 | 4 | 0000950170-25-075892 | 5224 | ||||||
| 2025-05-21 | 4 | 4 | 0000950170-25-075891 | 5180 | ||||||
| 2025-05-21 | 4 | 4 | 0000950170-25-075890 | 5236 | ||||||
| 2025-05-21 | 4 | 4 | 0000950170-25-075889 | 5192 | ||||||
| 2025-05-21 | 4 | 4 | 0000950170-25-075888 | 6705 | ||||||
| 2025-05-21 | 8-K | 8-K | 5.07,9.01 | 0000950170-25-075805 | 001-40355 | 25973534 | 34 | 191920 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001344676-25-000030 | 005-93221 | 25954044 | 34 | 20328 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-002231 | 005-93221 | 25951874 | 34 | 10669 | |||
| 2025-05-12 | 4 | 4 | 0000950170-25-069492 | 6422 | ||||||
| 2025-05-09 | S-8 | S-8 | 0000950170-25-067555 | 333-287119 | 25928527 | 33 | 376934 | |||
| 2025-05-08 | 10-Q | 10-Q | 0000950170-25-066953 | 001-40355 | 25926151 | 34 | 7395458 | 1 | 1 | |
| 2025-05-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-066915 | 001-40355 | 25925934 | 34 | 613630 | 1 | 1 |
| 2025-04-07 | DEF 14A | DEF 14A | 0000950170-25-051369 | 001-40355 | 25816428 | 34 | 43148193 | 1 | 1 | |
| 2025-04-07 | ARS | ARS | 0000950170-25-051368 | 001-40355 | 25816426 | 34 | 6851900 | |||
| 2025-04-07 | 8-K | 8-K | 5.02,9.01 | 0000950170-25-051362 | 001-40355 | 25816409 | 34 | 212612 | 1 | 1 |
| 2025-04-07 | DEFA14A | DEFA14A | 0000950170-25-051363 | 001-40355 | 25816408 | 34 | 1551606 | |||
| 2025-03-19 | 4 | 4 | 0000950170-25-042291 | 9060 | ||||||
| 2025-03-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-001980 | 001-40355 | 25745221 | 33 | 4807 | |||
| 2025-03-11 | 4 | 4 | 0000950170-25-037575 | 6085 | ||||||
| 2025-03-11 | 4 | 4 | 0000950170-25-037574 | 9416 | ||||||
| 2025-03-11 | 4 | 4 | 0000950170-25-037572 | 6104 | ||||||
| 2025-03-11 | 4 | 4 | 0000950170-25-037569 | 6118 | ||||||
| 2025-03-11 | 4 | 4 | 0000950170-25-037566 | 6070 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032626 | 8472 | ||||||
| 2025-02-27 | 10-K | 10-K | 0000950170-25-029029 | 001-40355 | 25678692 | 34 | 62845943 | 1 | 1 | |
| 2025-02-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-029009 | 001-40355 | 25678611 | 34 | 704922 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-001270 | 005-93221 | 25631049 | 34 | 10682 | |||
| 2025-02-03 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000201 | 005-93221 | 25583147 | 34 | 8126 | |||
| 2025-01-24 | 4 | 4 | 0000950170-25-008974 | 5118 | ||||||
| 2025-01-24 | 4 | 4 | 0000950170-25-008973 | 5136 | ||||||
| 2025-01-24 | 4 | 4 | 0000950170-25-008972 | 5149 | ||||||
| 2025-01-24 | 4 | 4 | 0000950170-25-008971 | 8446 | ||||||
| 2025-01-24 | 4 | 4 | 0000950170-25-008970 | 5212 | ||||||
| 2025-01-14 | 4 | 4 | 0000950170-25-005582 | 5276 | ||||||
| 2025-01-14 | 4 | 4 | 0000950170-25-005580 | 4835 | ||||||
| 2025-01-14 | 4 | 4 | 0000950170-25-005579 | 4635 | ||||||
| 2025-01-14 | 4 | 4 | 0000950170-25-005578 | 4603 | ||||||
| 2025-01-14 | 4 | 4 | 0000950170-25-005577 | 7932 | ||||||
| 2025-01-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-004578 | 001-40355 | 25524901 | 34 | 11808834 | 1 | 1 |
| 2024-12-05 | 4 | 4 | 0000950170-24-133720 | 7039 | ||||||
| 2024-12-05 | 3 | 3 | 0000950170-24-133716 | 19189 | ||||||
| 2024-11-14 | SC 13G | armistice-tmci093024.htm | 0001172661-24-005109 | 005-93221 | 241461129 | 34 | 90781 | |||
| 2024-11-13 | 4 | 4 | 0000950170-24-126551 | 6434 | ||||||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__TreaceMedi.txt | 0000932471-24-001303 | 005-93221 | 241450353 | 34 | 6583 | |||
| 2024-11-08 | SC 13G | MS INITIAL | 0000895421-24-000631 | 005-93221 | 241440243 | 34 | 12699 | |||
| 2024-11-07 | SC 13G/A | SC 13G/A | 0000950170-24-123492 | 005-93221 | 241436871 | 34 | 68491 | |||
| 2024-11-05 | 10-Q | 10-Q | 0000950170-24-121460 | 001-40355 | 241427510 | 34 | 7136972 | 1 | 1 | |
| 2024-11-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-121456 | 001-40355 | 241427451 | 34 | 592987 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__TreaceMedi.txt | 0000932471-24-000731 | 005-93221 | 241422497 | 34 | 5626 | |||
| 2024-10-15 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-114699 | 001-40355 | 241372111 | 34 | 207694 | 1 | 1 |
| 2024-10-02 | 4 | 4 | 0000950170-24-111853 | 5101 | ||||||
| 2024-09-17 | 4 | 4 | 0000950170-24-107401 | 8473 | ||||||
| 2024-09-16 | 4 | 4 | 0000950170-24-106856 | 6921 | ||||||
| 2024-08-19 | 4 | 4 | 0000950170-24-098286 | 5609 | ||||||
| 2024-08-15 | 4 | 4 | 0000950170-24-097694 | 8473 | ||||||
| 2024-08-09 | 4 | 4 | 0000950170-24-095010 | 5069 | ||||||
| 2024-08-09 | 4 | 4 | 0000950170-24-095009 | 5087 | ||||||
| 2024-08-09 | 4 | 4 | 0000950170-24-095008 | 5742 | ||||||
| 2024-08-09 | 4 | 4 | 0000950170-24-095007 | 5101 | ||||||
| 2024-08-06 | 10-Q | 10-Q | 0000950170-24-091787 | 001-40355 | 241179234 | 34 | 6870992 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-091777 | 001-40355 | 241179124 | 34 | 581953 | 1 | 1 |
| 2024-06-11 | 4 | 4 | 0000950170-24-072078 | 8474 | ||||||
| 2024-06-03 | 4 | 4 | 0000950170-24-068023 | 5609 | ||||||
| 2024-05-30 | 4 | 4 | 0000950170-24-066745 | 5609 | ||||||
| 2024-05-29 | 4 | 4 | 0000950170-24-065984 | 5608 | ||||||
| 2024-05-28 | 4 | 4 | 0000950170-24-065263 | 5038 | ||||||
| 2024-05-23 | 4 | 4 | 0000950170-24-063988 | 5038 | ||||||
| 2024-05-22 | 4 | 4 | 0000950170-24-063614 | 7659 | ||||||
| 2024-05-22 | 4 | 4 | 0000950170-24-063616 | 7647 | ||||||
| 2024-05-22 | 4 | 4 | 0000950170-24-063612 | 7404 | ||||||
| 2024-05-22 | 4 | 4 | 0000950170-24-063617 | 9186 | ||||||
| 2024-05-22 | 4 | 4 | 0000950170-24-063613 | 7651 | ||||||
| 2024-05-22 | 4 | 4 | 0000950170-24-063615 | 7703 | ||||||
| 2024-05-22 | 4 | 4 | 0000950170-24-063611 | 7691 | ||||||
| 2024-05-22 | 8-K | 8-K | 5.07,9.01 | 0000950170-24-063565 | 001-40355 | 24974182 | 34 | 199812 | 1 | 1 |
| 2024-05-20 | 4 | 4 | 0000950170-24-062435 | 8476 | ||||||
| 2024-05-14 | 4 | 4 | 0000950170-24-059856 | 5027 | ||||||
| 2024-05-14 | 4 | 4 | 0000950170-24-059854 | 8483 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058990 | 4491 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058989 | 6984 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058986 | 7517 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058974 | 6508 | ||||||
| 2024-05-13 | 4 | 4 | 0000950170-24-058878 | 10431 | ||||||
| 2024-05-09 | S-8 | S-8 | 0000950170-24-057076 | 333-279266 | 24931261 | 33 | 237109 | |||
| 2024-05-07 | 10-Q | 10-Q | 0000950170-24-054480 | 001-40355 | 24921909 | 34 | 6636511 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-054475 | 001-40355 | 24921861 | 34 | 8689697 | 1 | 1 |
| 2024-04-02 | DEFA14A | DEFA14A | 0000950170-24-040229 | 001-40355 | 24814729 | 34 | 1230872 | |||
| 2024-04-02 | DEF 14A | DEF 14A | 0000950170-24-040228 | 001-40355 | 24814730 | 34 | 2587051 | |||
| 2024-04-02 | ARS | ARS | 0000950170-24-040137 | 001-40355 | 24814132 | 34 | 3658811 | |||
| 2024-03-29 | 4 | 4 | 0000950170-24-038822 | 11106 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030473 | 6088 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030474 | 6766 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030472 | 9425 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030429 | 6103 | ||||||
| 2024-03-12 | 4 | 4 | 0000950170-24-030426 | 6124 | ||||||
| 2024-02-27 | 10-K | 10-K | 0000950170-24-021228 | 001-40355 | 24687333 | 34 | 25692966 | 1 | 1 | |
| 2024-02-27 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-021152 | 001-40355 | 24686871 | 34 | 11816657 | 1 | 1 |
| 2024-02-14 | SC 13G/A | SEC SCHEDULE 13G | 0001532155-24-000094 | 005-93221 | 24636645 | 34 | 18226 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-022127 | 005-93221 | 24629718 | 34 | 13088 | |||
| 2024-02-09 | SC 13G/A | SC 13G/A | 0000950170-24-013360 | 005-93221 | 24615905 | 34 | 68162 | |||
| 2024-01-29 | SC 13G | us89455t1097_012924.txt | 0001086364-24-005603 | 005-93221 | 24574947 | 34 | 13615 | |||
| 2024-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-24-001593 | 7883 | ||||||
| 2024-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-24-001592 | 7951 | ||||||
| 2024-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-24-001591 | 8550 | ||||||
| 2024-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-24-001590 | 8689 | ||||||
| 2024-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-24-001589 | 7887 | ||||||
| 2024-01-10 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-003448 | 001-40355 | 24524422 | 34 | 16417780 | 1 | 1 |
| 2024-01-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-002719 | 001-40355 | 24518461 | 34 | 212651 | 1 | 1 |
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-062068 | 001-40355 | 231392590 | 34 | 8915990 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-062026 | 001-40355 | 231392387 | 34 | 846940 | 1 | 1 |
| 2023-11-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-054434 | 4789 | ||||||
| 2023-11-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-054433 | 4727 | ||||||
| 2023-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-052266 | 4789 | ||||||
| 2023-08-09 | 10-Q | 10-Q | 0000950170-23-040159 | 001-40355 | 231153450 | 34 | 8954362 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-039795 | 001-40355 | 231151293 | 34 | 939983 | 1 | 1 |
| 2023-06-14 | 144 | xsl144X01/primary_doc.xml | 0001972362-23-000393 | 001-40355 | 231015417 | 33 | 4570 | |||
| 2023-06-13 | 8-K | 8-K | 2.01,9.01 | 0000950170-23-027758 | 001-40355 | 231012092 | 34 | 231852 | 1 | 1 |
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-035400 | 5971 | ||||||
| 2023-06-05 | 144 | xsl144X01/primary_doc.xml | 0001958244-23-000842 | 001-40355 | 23994068 | 33 | 11888 | |||
| 2023-06-02 | 144 | xsl144X01/primary_doc.xml | 0001958244-23-000837 | 001-40355 | 23990518 | 33 | 11104 | |||
| 2023-06-01 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-23-025707 | 001-40355 | 23984915 | 34 | 4110442 | 1 | 1 |
| 2023-05-26 | 8-K | 8-K | 5.07 | 0000950170-23-024559 | 001-40355 | 23970346 | 34 | 220464 | 1 | 1 |
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032353 | 7961 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032351 | 8484 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032352 | 7906 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032355 | 7949 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032350 | 7902 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032354 | 9482 | ||||||
| 2023-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-032349 | 7661 | ||||||
| 2023-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-030857 | 9523 | ||||||
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019154 | 001-40355 | 23900057 | 34 | 8008073 | 1 | 1 | |
| 2023-05-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-018823 | 001-40355 | 23897908 | 34 | 695523 | 1 | 1 |
| 2023-05-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-026796 | 10076 | ||||||
| 2023-05-01 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000031 | 001-40355 | 23871671 | 33 | 7142 | |||
| 2023-04-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-026167 | 7187 | ||||||
| 2023-04-26 | 144 | xsl144X01/primary_doc.xml | 0001958244-23-000473 | 001-40355 | 23850822 | 33 | 13486 | |||
| 2023-04-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-024260 | 9283 | ||||||
| 2023-04-11 | 144 | xsl144X01/primary_doc.xml | 0001958244-23-000446 | 001-40355 | 23813933 | 33 | 11840 | |||
| 2023-04-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-023948 | 5295 | ||||||
| 2023-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-23-023543 | 6900 | ||||||
| 2023-04-04 | ARS | ARS | 0000950170-23-011795 | 001-40355 | 23798836 | 34 | 4534793 | |||
| 2023-04-04 | DEFA14A | DEFA14A | 0000950170-23-011693 | 001-40355 | 23795103 | 34 | 3300323 | |||
| 2023-04-04 | DEF 14A | DEF 14A | 0000950170-23-011691 | 001-40355 | 23795095 | 34 | 3104079 | |||
| 2023-03-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-021956 | 7432 | ||||||
| 2023-03-31 | 4 | FORM 4 SUBMISSION | 0001209191-23-021955 | 5891 | ||||||
| 2023-03-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-021741 | 7189 | ||||||
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-019944 | 9511 | ||||||
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-019943 | 6987 | ||||||
| 2023-03-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-019078 | 9249 | ||||||
| 2023-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-018046 | 13142 | ||||||
| 2023-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-018044 | 9766 | ||||||
| 2023-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-018045 | 10551 | ||||||
| 2023-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-018043 | 9768 | ||||||
| 2023-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-018042 | 9737 | ||||||
| 2023-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-018041 | 9843 | ||||||
| 2023-03-10 | 4 | FORM 4 SUBMISSION | 0001209191-23-018040 | 8478 | ||||||
| 2023-03-10 | 8-K | 8-K | 8.01 | 0000950170-23-007283 | 001-40355 | 23723744 | 34 | 166216 | 1 | 1 |
| 2023-03-08 | S-8 | S-8 | 0001193125-23-064488 | 333-270352 | 23716182 | 33 | 89041 | |||
| 2023-03-08 | 10-K | 10-K | 0000950170-23-006603 | 001-40355 | 23714977 | 34 | 21425162 | 1 | 1 | |
| 2023-03-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-006457 | 001-40355 | 23712656 | 34 | 943413 | 1 | 1 |
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-016093 | 5265 | ||||||
| 2023-03-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-015075 | 7949 | ||||||
| 2023-02-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-012441 | 7155 | ||||||
| 2023-02-23 | 8-K | 8-K | 5.02 | 0000950170-23-004148 | 001-40355 | 23660270 | 34 | 167882 | 1 | 1 |
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010955 | 9252 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010852 | 7942 | ||||||
| 2023-02-14 | 5 | FORM 5 SUBMISSION | 0001209191-23-009582 | 6368 | ||||||
| 2023-02-14 | SC 13G | SEC SCHEDULE 13G | 0001532155-23-000056 | 005-93221 | 23620858 | 34 | 18137 | |||
| 2023-02-13 | SC 13G/A | SC 13G/A | 0001193125-23-035743 | 005-93221 | 23618385 | 34 | 41084 | |||
| 2023-02-13 | SC 13G/A | SC 13G/A | 0001193125-23-035682 | 005-93221 | 23618184 | 34 | 41579 | |||
| 2023-02-10 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-23-032511 | 001-40355 | 23611677 | 34 | 457035 | 1 | 1 |
| 2023-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-008200 | 7155 | ||||||
| 2023-02-09 | SC 13G | SCHEDULE 13G | 0001104659-23-017129 | 005-93221 | 23604428 | 34 | 12954 | |||
| 2023-02-09 | 424B5 | 424B5 | 0001193125-23-028748 | 333-269622 | 23600642 | 33 | 1032244 | |||
| 2023-02-07 | 424B5 | 424B5 | 0001193125-23-027039 | 333-269622 | 23595929 | 33 | 1006927 | |||
| 2023-02-07 | S-3ASR | S-3ASR | 0001193125-23-026932 | 333-269622 | 23595233 | 33 | 640515 | |||
| 2023-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-007201 | 4734 | ||||||
| 2023-02-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-006465 | 5858 | ||||||
| 2023-01-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-005547 | 10047 | ||||||
| 2023-01-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-005543 | 9538 | ||||||
| 2023-01-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-005131 | 9251 | ||||||
| 2023-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-004342 | 6985 | ||||||
| 2023-01-19 | 4 | FORM 4 SUBMISSION | 0001209191-23-004143 | 5265 | ||||||
| 2023-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-003385 | 9252 | ||||||
| 2023-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-003384 | 7400 | ||||||
| 2023-01-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-003383 | 9582 | ||||||
| 2023-01-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-002675 | 7399 | ||||||
| 2023-01-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-000442 | 001-40355 | 23516691 | 34 | 231086 | 1 | 1 |
| 2022-12-30 | 4 | FORM 4 SUBMISSION | 0001209191-22-063055 | 5266 | ||||||
| 2022-12-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-062379 | 7156 | ||||||
| 2022-12-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-061757 | 6988 | ||||||
| 2022-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-061323 | 5860 | ||||||
| 2022-12-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-060617 | 7148 | ||||||
| 2022-12-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-059533 | 7254 | ||||||
| 2022-12-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-059532 | 14625 | ||||||
| 2022-11-30 | 4 | FORM 4 SUBMISSION | 0001209191-22-059128 | 7150 | ||||||
| 2022-11-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-058549 | 13879 | ||||||
| 2022-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-058268 | 4685 | ||||||
| 2022-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-058266 | 8631 | ||||||
| 2022-11-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-058000 | 6985 | ||||||
| 2022-11-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-057743 | 5298 | ||||||
| 2022-11-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-057740 | 9409 | ||||||
| 2022-11-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-057654 | 8632 | ||||||
| 2022-11-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-057418 | 9202 | ||||||
| 2022-11-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-056467 | 11337 | ||||||
| 2022-11-09 | 10-Q | 10-Q | 0000950170-22-023530 | 001-40355 | 221370791 | 34 | 7803550 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023221 | 001-40355 | 221369009 | 34 | 914589 | 1 | 1 |
| 2022-11-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-055176 | 5193 | ||||||
| 2022-11-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-055133 | 5162 | ||||||
| 2022-10-26 | 4 | FORM 4 SUBMISSION | 0001209191-22-054666 | 7665 | ||||||
| 2022-10-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-054342 | 10050 | ||||||
| 2022-10-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-054211 | 9237 | ||||||
| 2022-10-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-053169 | 7155 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052526 | 7565 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052525 | 7566 | ||||||
| 2022-10-04 | 3 | FORM 3 SUBMISSION | 0001209191-22-052448 | 7167 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052447 | 7772 | ||||||
| 2022-10-04 | 3 | FORM 3 SUBMISSION | 0001209191-22-052446 | 7301 | ||||||
| 2022-09-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-051555 | 7155 | ||||||
| 2022-09-28 | 8-K | 8-K | 5.02,9.01 | 0000950170-22-018920 | 001-40355 | 221272465 | 34 | 209163 | 1 | 1 |
| 2022-09-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-050424 | 8047 | ||||||
| 2022-09-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-050143 | 11337 | ||||||
| 2022-09-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-048607 | 14696 | ||||||
| 2022-09-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-048290 | 8638 | ||||||
| 2022-08-31 | 4 | FORM 4 SUBMISSION | 0001209191-22-048172 | 7161 | ||||||
| 2022-08-29 | 4 | FORM 4 SUBMISSION | 0001209191-22-047786 | 8638 | ||||||
| 2022-08-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-047407 | 10735 | ||||||
| 2022-08-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-046956 | 7959 | ||||||
| 2022-08-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-046491 | 6988 | ||||||
| 2022-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-046000 | 8826 | ||||||
| 2022-08-10 | 10-Q | 10-Q | 0000950170-22-016277 | 001-40355 | 221150600 | 34 | 10548494 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016039 | 001-40355 | 221148281 | 34 | 812117 | 1 | 1 |
| 2022-08-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-044621 | 11584 | ||||||
| 2022-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-044026 | 9352 | ||||||
| 2022-07-20 | 4 | FORM 4 | 0001567619-22-014272 | 9726 | ||||||
| 2022-07-15 | 4 | FORM 4 | 0001567619-22-014078 | 9728 | ||||||
| 2022-07-06 | 4 | FORM 4 | 0001567619-22-013730 | 8542 | ||||||
| 2022-06-21 | 4 | FORM 4 | 0001567619-22-013208 | 7860 | ||||||
| 2022-06-03 | 4 | FORM 4 | 0001567619-22-012339 | 8541 | ||||||
| 2022-05-27 | 4 | FORM 4 | 0001567619-22-011883 | 7863 | ||||||
| 2022-05-23 | 8-K | 8-K | 5.07 | 0000950170-22-010494 | 001-40355 | 22951681 | 34 | 217767 | 1 | 1 |
| 2022-05-20 | 4 | FORM 4 | 0001567619-22-011443 | 5223 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001567619-22-011345 | 11575 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001567619-22-011344 | 9545 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001567619-22-011343 | 7264 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001567619-22-011342 | 11516 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001567619-22-011341 | 7299 | ||||||
| 2022-05-19 | 4 | FORM 4 | 0001567619-22-011340 | 8769 | ||||||
| 2022-05-11 | 4 | FORM 4 | 0001567619-22-010102 | 8543 | ||||||
| 2022-05-11 | 4 | FORM 4 | 0001567619-22-010101 | 12675 | ||||||
| 2022-05-06 | 10-Q | 10-Q | 0000950170-22-008018 | 001-40355 | 22899029 | 34 | 6519887 | 1 | 1 | |
| 2022-05-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-007826 | 001-40355 | 22896342 | 34 | 617798 | 1 | 1 |
| 2022-05-04 | 8-K | 8-K | 1.01,1.02,2.03,9.01 | 0000950170-22-007143 | 001-40355 | 22889079 | 34 | 246005 | 1 | 1 |
| 2022-04-04 | DEFA14A | DEFA14A | 0000950170-22-005335 | 001-40355 | 22802977 | 34 | 395591 | |||
| 2022-04-04 | DEF 14A | DEF 14A | 0000950170-22-005330 | 001-40355 | 22802735 | 34 | 1665086 | |||
| 2022-03-22 | SC 13G/A | TREACE MEDICAL 13 G AMENDMENT | 0001298088-22-000008 | 005-93221 | 22757699 | 34 | 9003 | |||
| 2022-03-14 | 4 | FORM 4 | 0001567619-22-006929 | 7494 | ||||||
| 2022-03-14 | 3 | FORM 3 | 0001567619-22-006926 | 14784 | ||||||
| 2022-03-14 | 4 | FORM 4 | 0001567619-22-006925 | 6917 | ||||||
| 2022-03-10 | 4 | FORM 4 | 0001567619-22-006734 | 7480 | ||||||
| 2022-03-10 | 4 | FORM 4 | 0001567619-22-006733 | 7479 | ||||||
| 2022-03-10 | 4 | FORM 4 | 0001567619-22-006732 | 9483 | ||||||
| 2022-03-10 | 4 | FORM 4 | 0001567619-22-006731 | 4484 | ||||||
| 2022-03-10 | 4 | FORM 4 | 0001567619-22-006730 | 13024 | ||||||
| 2022-03-10 | 4 | FORM 4 | 0001567619-22-006729 | 8149 | ||||||
| 2022-03-10 | 4 | FORM 4 | 0001567619-22-006728 | 5347 | ||||||
| 2022-03-10 | 4 | FORM 4 | 0001567619-22-006727 | 9118 | ||||||
| 2022-03-10 | 4 | FORM 4 | 0001567619-22-006726 | 7474 | ||||||
| 2022-03-04 | S-8 | S-8 | 0001193125-22-066349 | 333-263327 | 22715421 | 33 | 78399 | |||
| 2022-03-04 | 4 | FORM 4 | 0001567619-22-006400 | 8817 | ||||||
| 2022-03-04 | 10-K | 10-K | 0000950170-22-002903 | 001-40355 | 22714089 | 34 | 18437545 | 1 | 1 | |
| 2022-03-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-002793 | 001-40355 | 22708658 | 34 | 795058 | 1 | 1 |
| 2022-02-25 | 8-K | 8-K | 5.02 | 0000950170-22-002108 | 001-40355 | 22680683 | 34 | 186602 | 1 | 1 |
| 2022-02-11 | 5 | FORM 5 | 0001567619-22-003544 | 16532 | ||||||
| 2022-02-11 | 5 | FORM 5 | 0001567619-22-003543 | 6523 | ||||||
| 2022-02-11 | SC 13G | SC 13G | 0001193125-22-037142 | 005-93221 | 22621518 | 34 | 42786 | |||
| 2022-02-11 | 5 | FORM 5 | 0001567619-22-003539 | 6796 | ||||||
| 2022-02-11 | SC 13G | SC 13G | 0001193125-22-037071 | 005-93221 | 22621185 | 34 | 42265 | |||
| 2022-02-10 | 4 | FORM 4 | 0001567619-22-003261 | 14360 | ||||||
| 2022-01-20 | 4 | FORM 4 | 0001567619-22-001384 | 10731 | ||||||
| 2022-01-12 | 4 | FORM 4 | 0001567619-22-001142 | 22110 | ||||||
| 2022-01-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-007689 | 001-40355 | 22526714 | 34 | 166689 | 1 | 1 |
| 2022-01-07 | SC 13G/A | TREACE MEDICAL CONCEPTS | 0001298088-22-000002 | 005-93221 | 22516956 | 34 | 8438 | |||
| 2022-01-05 | 4 | FORM 4 | 0001567619-22-000672 | 19548 | ||||||
| 2021-12-30 | 4 | FORM 4 | 0001567619-21-022717 | 10713 | ||||||
| 2021-12-30 | 4 | FORM 4 | 0001567619-21-022714 | 6758 | ||||||
| 2021-12-27 | 4 | FORM 4 | 0001567619-21-022542 | 12698 | ||||||
| 2021-12-27 | 4 | FORM 4 | 0001567619-21-022541 | 11072 | ||||||
| 2021-12-22 | 4 | FORM 4 | 0001567619-21-022460 | 14681 | ||||||
| 2021-12-22 | 4 | FORM 4 | 0001567619-21-022459 | 21714 | ||||||
| 2021-12-17 | 4 | FORM 4 | 0001567619-21-022289 | 8747 | ||||||
| 2021-11-24 | 4 | FORM 4 | 0001567619-21-021185 | 15375 | ||||||
| 2021-11-24 | 4 | FORM 4 | 0001567619-21-021184 | 18643 | ||||||
| 2021-11-17 | 4 | FORM 4 | 0001567619-21-020693 | 17314 | ||||||
| 2021-11-12 | 4 | FORM 4 | 0001567619-21-020114 | 11007 | ||||||
| 2021-11-04 | 10-Q | 10-Q | 0001564590-21-054505 | 001-40355 | 211380284 | 34 | 8257363 | 1 | 1 | |
| 2021-11-04 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-054483 | 001-40355 | 211380056 | 34 | 657470 | 1 | 1 |
| 2021-10-22 | 4 | FORM 4 | 0001567619-21-018627 | 26920 | ||||||
| 2021-10-22 | 4 | FORM 4 | 0001567619-21-018626 | 8893 | ||||||
| 2021-10-08 | 4 | FORM 4 | 0001567619-21-018153 | 7468 | ||||||
| 2021-10-04 | 4 | FORM 4 | 0001567619-21-017869 | 5540 | ||||||
| 2021-10-04 | 4 | FORM 4 | 0001567619-21-017868 | 5481 | ||||||
| 2021-10-04 | 3 | FORM 3 | 0001567619-21-017867 | 11698 | ||||||
| 2021-10-04 | 3 | FORM 3 | 0001567619-21-017866 | 11554 | ||||||
| 2021-10-04 | 8-K | 8-K NEW DIRECTORS | 5.02,9.01 | 0001564590-21-049869 | 001-40355 | 211300902 | 34 | 217904 | 1 | 1 |
| 2021-09-21 | 4 | FORM 4 | 0001567619-21-017391 | 5504 | ||||||
| 2021-09-21 | 3 | FORM 3 | 0001567619-21-017390 | 11548 | ||||||
| 2021-08-05 | 4 | FORM 4 | 0001567619-21-014559 | 5485 | ||||||
| 2021-08-05 | 3 | FORM 3 | 0001567619-21-014557 | 12909 | ||||||
| 2021-08-05 | 10-Q | 10-Q | 0001564590-21-041667 | 001-40355 | 211149050 | 34 | 8446776 | 1 | 1 | |
| 2021-08-05 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-041660 | 001-40355 | 211149015 | 34 | 627800 | 1 | 1 |
| 2021-05-28 | 10-Q/A | 10-Q/A | 0001193125-21-177028 | 001-40355 | 21980642 | 34 | 46759 | |||
| 2021-05-25 | 10-Q | 10-Q | 0001193125-21-172315 | 001-40355 | 21960679 | 34 | 4249648 | 1 | ||
| 2021-05-25 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-172298 | 001-40355 | 21960605 | 34 | 113203 | ||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017495 | 10556 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017486 | 13980 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017480 | 9920 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017476 | 11513 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017474 | 6250 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017470 | 13649 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017465 | 10089 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017462 | 17927 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017461 | 16038 | ||||||
| 2021-04-29 | 4 | FORM 4 SUBMISSION | 0000899243-21-017458 | 9293 |
One latest value per concept from companyfacts (289 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 65.56M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 265.90M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 212.70M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | -497,833 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 3.06M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 76.03 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | -246,428 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 5.41M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 13.14 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 957.81 | 2026-05-08 | S-8 | 2026-05-08 | 0001630627-26-000011 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 957.81 | 2026-05-08 | S-8 | 2026-05-08 | 0001630627-26-000011 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 6.94M | 2026-05-08 | S-8 | 2026-05-08 | 0001630627-26-000011 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-08 | S-8 | 2026-05-08 | 0001630627-26-000011 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 14.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 30.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | -15,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | AccruedInsuranceCurrentAndNoncurrent | Accrued Insurance | USD | 200,000 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-08 | 0001193125-26-213322 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 7.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 3.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AccruedProfessionalFeesCurrentAndNoncurrent | Accrued Professional Fees | USD | 1.60M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-08 | 0001193125-26-213322 | |
| us-gaap | AccruedRoyaltiesCurrentAndNoncurrent | Accrued Royalties | USD | 1.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 26.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -108,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 358.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 6.93M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 2.30M | 2021-04-27 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 595,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 6.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 21.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 1.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableCurrent | Accounts Receivable, Allowance for Credit Loss, Current | USD | 1.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 2.10M | 2024-04-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0000950170-24-091787 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 300,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029029 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 747,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 14.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | Assets | Assets | USD | 179.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 118.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 32.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedGain | Debt Securities, Available-for-sale, Unrealized Gain | USD | 1,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | Debt Securities, Available-for-sale, Unrealized Loss | USD | 109,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 32.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | BusinessCombinationAcquisitionRelatedCosts | Business Combination, Acquisition Related Costs | USD | 0 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| us-gaap | CapitalizedComputerSoftwareAdditions | Capitalized Computer Software, Additions | USD | 200,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 |
| us-gaap | Cash | Cash | USD | 5.36M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029029 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 7.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -7.35M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-06 | 0000950170-22-008018 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 7.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -2.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 85.84M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023530 | |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 0 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054480 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 4.022 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 713,330 | 2019-02-14 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 | |
| us-gaap | CommitmentsAndContingencies | Commitments and Contingencies | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062068 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 17.31M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029029 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 65.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 62.28M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-05 | 0000950170-24-121460 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 66,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -46.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | ContractWithCustomerRefundLiability | Contract with Customer, Refund Liability | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ContractWithCustomerRightToRecoverProduct | Contract with Customer, Right to Recover Product | USD | 0 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 | |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 6.69M | 2021-04-27 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 29.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 60.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 3.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 3.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054505 | |
| us-gaap | DeferredTaxAssetInterestCarryforward | Deferred Tax Asset, Interest Carryforward | USD | 3.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 908,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 60.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 2.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 3.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 38.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 2.17M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 2.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Bonuses | USD | 726,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 6.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 56.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 17,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxLiabilitiesOtherFiniteLivedAssets | Deferred Tax Liabilities, Other Finite-Lived Assets | USD | 1.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 1.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | DefinedBenefitPlanContributionsByEmployer | Defined Benefit Plan, Plan Assets, Contributions by Employer | USD | 2.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | Depreciation | Depreciation | USD | 3.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 10.62M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 4.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 200,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 | |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 2.50M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054505 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.71 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.16 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-06 | 0000950170-22-008018 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.71 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.13 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.09 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 10.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 4.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-054480 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 0 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023530 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 3.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 2.74M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 47.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | Goodwill | Goodwill | USD | 12.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | GrossProfit | Gross Profit | USD | 111.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | ImpairmentOfLeasehold | Impairment of Leasehold | USD | 100,000 | 2022-10-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029029 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029029 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 8.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -12.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 315,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 5.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -456,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 697,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 7.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -11.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 3.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 6.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 272,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | IncreaseDecreaseInOtherOperatingCapitalNet | Increase (Decrease) in Other Operating Assets and Liabilities, Net | USD | -391,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -119,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 864,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 6.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | InterestExpense | Interest Expense | USD | 4.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 2.92M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054505 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 3.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 574,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 42.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062068 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 1.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 2.00M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 19.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 5.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.86M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 3.29M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 3.22M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 3.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 3.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 627,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 5.42M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | Liabilities | Liabilities | USD | 117.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 179.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LiabilitiesAssumed1 | Liabilities Assumed | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 46.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LiabilitiesFairValueAdjustment | Liabilities, Fair Value Adjustment | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029029 |
| us-gaap | LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage | Line of Credit Facility, Unused Capacity, Commitment Fee Percentage | pure | 0.005 | 2025-12-17 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 56.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LongTermDebtCurrent | Long-term Debt, Current Maturities | USD | 1.79M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive | Long-Term Debt, Maturity, after Year Five | USD | 20.67M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023530 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 60.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 56.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | LongTermDebtPercentageBearingFixedInterestRate | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate | pure | 0.13 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 | |
| us-gaap | LongTermLineOfCredit | Long-term Line of Credit, Noncurrent | USD | 0 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-25 | 0001193125-21-172315 | |
| us-gaap | LossContingencyAccrualProductLiabilityNet | Loss Contingency Accrual, Product Liability, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 32.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -180,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -227,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -2.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -713,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -46.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -49.53M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 155.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -43.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 14.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 12.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 3.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 6.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 2.32M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 627,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 321,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 472,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 458,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 444,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 172,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054505 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 600,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.094 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 1.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | OtherAccruedLiabilitiesCurrentAndNoncurrent | Other Accrued Liabilities | USD | 856,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054505 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -56,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 523,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 2.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -1.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -2.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | 640,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | OtherReceivableAllowanceForCreditLossNoncurrent | OtherReceivableAllowanceForCreditLossNoncurrent | USD | 17,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 600,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 |
| us-gaap | PaymentsForUnderwritingExpense | Payments for Underwriting Expense | USD | 8.30M | 2021-04-27 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 | |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 8,000 | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-25 | 0001193125-21-172315 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 7.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 641,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 26.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | PaymentsToAcquireBusinessesGross | Payments to Acquire Businesses, Gross | USD | 2.10M | 2025-01-15 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029029 | |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 140.07M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062068 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 7.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | PreferredStockDividendRatePercentage | Preferred Stock, Dividend Rate, Percentage | pure | 0.08 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054505 |
| us-gaap | PreferredStockDividendsAndOtherAdjustments | Preferred Stock Dividends and Other Adjustments | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 6.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 |
| us-gaap | ProceedsFromIssuanceOfOtherLongTermDebt | Proceeds from Issuance of Other Long-term Debt | USD | 1.80M | 2020-04-22 | 2021 | Q1 | 10-Q | 2021-05-25 | 0001193125-21-172315 | |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 600,000 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 31.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 107,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | ProductLiabilityContingencyAccrualPresentValue | Product Liability Contingency, Accrual, Present Value | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 | |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -46.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 59.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 33.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 700,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | RentalIncomeNonoperating | Rental Income, Nonoperating | USD | 300,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062068 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0000950170-24-021228 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 13.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 1.53M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001630627-26-000005 | ||
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -295.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | Revenues | Revenues | USD | 140.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0000950170-25-029029 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 17 | 2021-04-27 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 | |
| us-gaap | SellingAndMarketingExpense | Selling and Marketing Expense | USD | 94.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 21.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | 14.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.492 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-04 | 0000950170-22-002903 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.379 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.378 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.048 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062068 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.044 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.04 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate | pure | 0.611 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062068 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 1.29M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-25 | 0001193125-21-172315 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 6.11M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 10.85 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 5,183 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-25 | 0001193125-21-172315 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 877,910 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062068 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.96 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 2.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 7.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 11.97 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 2.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 2.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 7.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 11.91 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 500,000 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-25 | 0001193125-21-172315 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.53 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 13.86 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | SharePrice | Share Price | USD/shares | 31.27 | 2021-04-28 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054505 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 3.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 61.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 1.338 | 2021-04-16 | 2022 | FY | 10-K | 2023-03-08 | 0000950170-23-006603 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 356,446 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 107.53M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 8,000 | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-07 | 0001630627-26-000018 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 800,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | TreasuryStockCommonShares | Treasury Stock, Common, Shares | shares | 348,299 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | TreasuryStockValue | Treasury Stock, Value | USD | 1.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 12.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 1.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-27 | 0001193125-26-079167 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 65.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 54.83M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-06 | 0000950170-22-008018 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 65.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-06 | 0001193125-26-450722 |